BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 3219995)

  • 21. Ciprofloxacin in the treatment of urinary and respiratory tract infections in patients with chronic liver disease.
    Galante D; Esposito S; Barba D; Giusti G
    Chemioterapia; 1986 Oct; 5(5):322-6. PubMed ID: 3791479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial efficacy of norfloxacin, trimethoprim-sulfamethoxazole, and gentamicin in experimentally-infected normal and streptozotocin-induced diabetic mice.
    Fromtling RA; Abruzzo GK; Gadebusch HH
    Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):731-5. PubMed ID: 6241648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic efficacy of intravenous and oral ciprofloxacin in experimental murine infections.
    Nishino T; Obana Y
    Chemotherapy; 1996; 42(2):140-5. PubMed ID: 8697889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of ofloxacin (Tarivid) therapy in respiratory and urinary tract infections].
    Hasçelik G
    Mikrobiyol Bul; 1987 Jul; 21(3):165-71. PubMed ID: 3332699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temafloxacin vs ciprofloxacin for UTI.
    Ganiats TG; Norcross WA
    J Fam Pract; 1992 Jul; 35(1):14, 16, 18. PubMed ID: 1319461
    [No Abstract]   [Full Text] [Related]  

  • 26. Ofloxacin vs ciprofloxacin: a comparison.
    Nicolau D; Quintiliani R; Nightingale CH
    Conn Med; 1992 May; 56(5):261-3. PubMed ID: 1611900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two new fluoroquinolones.
    Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502
    [No Abstract]   [Full Text] [Related]  

  • 28. Temafloxacin vs ciprofloxacin for UTI.
    Hornstein LE
    J Fam Pract; 1992 Jul; 35(1):14; author reply 18. PubMed ID: 1319460
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
    Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
    Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.
    Belliveau P; Nightingale CH; Quintiliani R; Crowe H; Gousee G
    Conn Med; 1993 Aug; 57(8):539-45. PubMed ID: 8243083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease.
    Azoulay-Dupuis E; Bedos JP; Vallée E; Hardy DJ; Swanson RN; Pocidalo JJ
    J Infect Dis; 1991 Feb; 163(2):319-24. PubMed ID: 1988515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.
    Martin SJ; Jung R; Garvin CG
    Drug Saf; 2001; 24(3):199-222. PubMed ID: 11347723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical role of the quinolones today and in the future.
    Waldvogel FA
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1075-9. PubMed ID: 2620674
    [No Abstract]   [Full Text] [Related]  

  • 34. New uses for new and old quinolones and the challenge of resistance.
    Hooper DC
    Clin Infect Dis; 2000 Feb; 30(2):243-54. PubMed ID: 10671323
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic focus. The fluoroquinolones.
    James DG
    Br J Clin Pract; 1989 Feb; 43(2):66-7. PubMed ID: 2679837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fluoroquinolones--antibacterial activity, pharmacokinetics and indications for a new group of chemotherapeutic drugs].
    Naumann P; Dopp C
    Internist (Berl); 1989 Jan; 30(1):20-31. PubMed ID: 2646237
    [No Abstract]   [Full Text] [Related]  

  • 37. Ofloxacin in urinary tract infections.
    Kromann-Andersen B; Krøyer Nielsen K
    Scand J Infect Dis Suppl; 1990; 68():35-40. PubMed ID: 2218420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ofloxacin. A reappraisal of its use in the management of genitourinary tract infections.
    Onrust SV; Lamb HM; Balfour JA
    Drugs; 1998 Nov; 56(5):895-928. PubMed ID: 9829160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quinolone therapy in the prevention of mortality after irradiation.
    Brook I; Elliott TB
    Radiat Res; 1991 Oct; 128(1):100-3. PubMed ID: 1924719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of new quinolones on Mycoplasma pneumoniae-infected hamsters.
    Arai S; Gohara Y; Akashi A; Kuwano K; Nishimoto M; Yano T; Oizumi K; Takeda K; Yamaguchi T
    Antimicrob Agents Chemother; 1993 Feb; 37(2):287-92. PubMed ID: 8383942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.